AMA statement on NIH buprenorphine study
September 30, 2024
September 30, 2024
CHICAGO, Illinois, Sept. 30 [Category: Medical] -- The American Medical Association issued the following news release:
The following statement is attributable to:Bobby Mukkamala, MDPresident-elect of the American Medical Association Chair of the AMA Substance Use and Pain Care Task Force"The American Medical Association (AMA) welcomes new study findings from the National Institutes of Health that higher doses of buprenorphine may improve treatment outcomes for individuals with . . .
The following statement is attributable to:Bobby Mukkamala, MDPresident-elect of the American Medical Association Chair of the AMA Substance Use and Pain Care Task Force"The American Medical Association (AMA) welcomes new study findings from the National Institutes of Health that higher doses of buprenorphine may improve treatment outcomes for individuals with . . .